Editorial [Hot Topic: HIV-1 Reverse Transcriptase Inhibitors: Drug Resistance and Drug Development (Executive Editors: Nicolas Sluis-Cremer and Ted Ross)]

Nicolas      Sluis-Cremer; Ted      Ross

doi:10.2174/138161206776873635

Author(s): Nicolas Sluis-Cremer and Ted Ross

Volume 12, Issue 15, 2006

Page: [1809 - 1810] Pages: 2

DOI: 10.2174/138161206776873635

Download Options

Rights & Permissions Print Cite

Current Pharmaceutical Design

Title: Editorial [Hot Topic: HIV-1 Reverse Transcriptase Inhibitors: Drug Resistance and Drug Development (Executive Editors: Nicolas Sluis-Cremer and Ted Ross)]

Volume: 12 Issue: 15

Author(s): Nicolas Sluis-Cremer and Ted Ross

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Sluis-Cremer Nicolas and Ross Ted, Editorial [Hot Topic: HIV-1 Reverse Transcriptase Inhibitors: Drug Resistance and Drug Development (Executive Editors: Nicolas Sluis-Cremer and Ted Ross)], Current Pharmaceutical Design 2006; 12 (15) . https://dx.doi.org/10.2174/138161206776873635